Treatment of Actinic Keratosis via Destruction in Medicare Beneficiaries

This cohort study evaluates the use of destruction techniques to treat actinic keratoses among Medicare beneficiaries between 2016 and 2023, both overall and by clinician type.

Corresponding Author: Mackenzie R. Wehner, MD, MPhil, Department of Health Services Research and Dermatology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1738, Houston, TX 77030 (mwehner@mdanderson.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.